https://seekingalpha.com/article/4431871-moderna-s
Post# of 148288
(Total Views: 523)
Posted On: 05/28/2021 6:15:32 AM
https://seekingalpha.com/article/4431871-mode...hard-place
"The fight for 2022 COVID-19 vaccine supply will likely take place in Europe and lesser-developed countries."
Whether mgmt. has been lucky or good still needs to be determined, but the Philippines, India, Brazil strategy fits the point of this article. The question is:
"Will Cytodyn be able to deliver in 2022? They are positioned to do so, but execution has been questionable. Perhaps if the "FDA" of one of these countries approves EUA, the others will fall like dominoes. One can hope. Our FDA seems to be sending the message that Cytodyn's future, at least for COVID-19, is not in the US. Unquestionably, competition overseas will be steep.
"The fight for 2022 COVID-19 vaccine supply will likely take place in Europe and lesser-developed countries."
Whether mgmt. has been lucky or good still needs to be determined, but the Philippines, India, Brazil strategy fits the point of this article. The question is:
"Will Cytodyn be able to deliver in 2022? They are positioned to do so, but execution has been questionable. Perhaps if the "FDA" of one of these countries approves EUA, the others will fall like dominoes. One can hope. Our FDA seems to be sending the message that Cytodyn's future, at least for COVID-19, is not in the US. Unquestionably, competition overseas will be steep.
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼